Obesity is a major risk factor for cardiovascular disease, yet recent advancements in pharmacotherapy are transforming its management and improving patient outcomes. Despite their potential, the integration of these therapies into clinical practice remains a challenge. In this session, renowned Cardiologist Dr. PC Manoria will delve into the evolving role of obesity pharmacotherapy, discussing its impact on lipid metabolism, blood pressure regulation, and overall cardiovascular health. Join us to explore the latest evidence, clinical applications, and future directions in obesity management for cardiovascular risk reduction.